US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioStem Technologies, Inc.

4.21

+0.21005.25%

Pre-market: 4.15-0.0600-1.43%06:34 EDT

Volume:117.70K

Turnover:493.65K

Market Cap:75.07M

PE:-2.52

High:4.30

Open:4.05

Low:4.04

Close:4.00

52wk High:8.40

52wk Low:2.25

Shares:17.83M

Float Shares:14.04M

Volume Ratio:0.81

T/O Rate:0.84%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6713

EPS(LYR):-0.3934

ROE:-74.74%

ROA:-18.07%

PB:2.72

PE(LYR):-10.70

Loading ...

Overview Company News Filings

Biostem Technologies, Inc. Q1 EPS USD -0.52

THOMSON REUTERS

Biostem Technologies initiated with a Buy at H.C. Wainwright

Press Release: BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer

Biostem Strengthens Leadership Team With Appointment of Katherine Gorrell as Chief Legal & Compliance Officer

THOMSON REUTERS

Press Release: BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025

Press Release: BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BSEM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BSEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","market":"US","secType":"STK","nameCN":"BioStem Technologies, Inc.","latestPrice":4.21,"timestamp":1788984000000,"preClose":4,"halted":0,"volume":117704,"hourTrading":{"tag":"盘前","latestPrice":4.15,"preClose":4.21,"latestTime":"06:34 EDT","volume":7,"amount":29.050000000000004,"timestamp":1789036486601,"change":-0.06,"changeRate":-0.014252,"amplitude":0},"delay":0,"changeRate":0.05249999999999999,"floatShares":14042148,"shares":17831900,"eps":-1.671347,"marketStatus":"Pre-Mkt","change":0.21,"latestTime":"09-10 07:16:47 EDT","open":4.05,"high":4.3,"low":4.04,"amount":493654.46023200004,"amplitude":0.065,"askPrice":4.66,"askSize":100,"bidPrice":3.87,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.671347,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":4.21,"preHourTrading":{"tag":"盘前","latestPrice":4.15,"preClose":4.21,"latestTime":"06:34 EDT","volume":7,"amount":29.050000000000004,"timestamp":1789036486601,"change":-0.06,"changeRate":-0.014252,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.21,"preClose":4.21,"latestTime":"19:30 EDT","volume":100,"amount":421.609,"timestamp":1788996604504,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8052034752896675},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","floatShares":14042148,"roa":"-18.07%","roe":"-74.74%","lyrEps":-0.393388,"volumeRatio":0.8052034752896675,"shares":17831900,"dividePrice":0,"high":4.3,"amplitude":0.065,"preClose":4,"low":4.04,"week52Low":2.251,"pbRate":"2.72","psRate":"2.17","week52High":8.4,"institutionHeld":0,"latestPrice":4.21,"eps":-1.671347,"divideRate":0,"volume":117704,"delay":0,"ttmEps":-1.671347,"open":4.05,"prevYearClose":3.81,"prevWeekClose":3.71,"prevMonthClose":3.68,"prevQuarterClose":3.3,"fiveDayClose":3.5,"twentyDayClose":3.61,"sixtyDayClose":4.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BSEM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"BSEM","fiscalQuarterEnding":"2026/06","expectedEps":-0.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.52},{"date":"2026-05-14","symbol":"BSEM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778788800000,"name":null,"time":"Post-Mkt","dateTimestamp":1778731200000,"actualEps":null},{"date":"2026-03-24","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774339200000,"name":null,"time":"","dateTimestamp":1774324800000,"actualEps":null},{"date":"2025-11-13","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763024400000,"name":null,"time":"","dateTimestamp":1763010000000,"actualEps":null},{"date":"2025-08-14","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755158400000,"name":null,"time":"","dateTimestamp":1755144000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BSEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BSEM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1778126400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BSEM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BSEM","date":"2026-09-09","current":-2.518926,"percent":0.227273,"low":-3.757423,"twenty":-2.84597,"median":-2.321824,"eighty":-2.14958,"high":-1.892791,"avg":-2.497198,"sd":0.519486,"marketCap":71397884},"quantilePoints":[{"date":"2026-08-06","current":-3.060802,"twenty":-3.060802,"median":-3.060802,"eighty":-3.060802,"marketCap":59100221},{"date":"2026-08-14","current":-1.982708,"twenty":-3.488616,"median":-3.39222,"eighty":-3.060802,"marketCap":54952215},{"date":"2026-08-21","current":-2.321824,"twenty":-3.470255,"median":-2.321824,"eighty":-1.987431,"marketCap":65686053},{"date":"2026-08-28","current":-2.429082,"twenty":-3.314185,"median":-2.362834,"eighty":-2.067302,"marketCap":68720463},{"date":"2026-09-04","current":-2.277659,"twenty":-3.060802,"median":-2.309205,"eighty":-2.110462,"marketCap":64436590},{"date":"2026-09-09","current":-2.523722,"twenty":-2.84597,"median":-2.321824,"eighty":-2.14958,"marketCap":71397884}],"updateTime":1789039007782},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BSEM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635723381","title":"Biostem Technologies, Inc. Q1 EPS USD -0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723381?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789104,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX33198C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193653","title":"Biostem Technologies initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633193653?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:26","pubTimestamp":1778124401,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth initiated coverage of Biostem Technologies (BSEM) with a Buy rating and $9 price target While the de...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biostem-technologies-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biostem-technologies-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636324","title":"Press Release: BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636324","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636324?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:08","pubTimestamp":1777547280,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., April 30, 2026  -- BioStem Technologies , a leading regenerative medicine company focused on the development, manufacturing and commercialization of perinatal tissue allograft products, today announced the appointment of Katherine Gorrell as Chief Legal & Compliance Officer, effective April 27, 2026.Ms. Gorrell has an extensive career advising hospital systems and health technology companies, with deep experience in health law, regulatory, transactional, compliance, governance, and risk management, as well as other business-oriented legal functions that facilitate strategic expansion and ensure operational excellence. In her role, she will oversee BioStem's legal and compliance functions and play a central role in enterprise governance, including the integration and oversight of Medical Affairs through BioStem's compliance framework.\"Katherine is a key addition to BioStem as we implement our next phase of growth,\" said Jason Matuszewski, Chairman and CEO of BioStem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4007","BK4604","TISI","R","BK4588","BSEM","03160","BK4022","BK4232","BK4555","BK4585","TM","BK4120"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635813","title":"Biostem Strengthens Leadership Team With Appointment of Katherine Gorrell as Chief Legal & Compliance Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635813","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635813?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA72V02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311986","title":"Press Release: BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311986","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311986?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:02","pubTimestamp":1774868520,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., March 30, 2026  -- BioStem Technologies, Inc. , a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that it has filed its audited consolidated financial statements as of and for the fiscal years ended December 31, 2024 and 2025. The financial statements are available for review in their entirety on the OTC Markets website here. With the publication of the audited consolidated financial statements, BioStem has taken another significant step toward a Nasdaq uplisting.\"We are pleased to have published our audited financial statements for 2024 and 2025, which marks an important milestone for the Company. Along with the appointment of a new CFO, auditor and audit committee chair, this achievement highlights the significant effort we have made to establish robust financial reporting processes and positions the Company to advance our corporate initiatives, includin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4588","TM","BK4604","BK4585","BK4555","BK4007","03160","R","BK4099","BK4232","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621089777","title":"Press Release: BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2621089777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621089777?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:04","pubTimestamp":1774263840,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., March 23, 2026  -- BioStem Technologies , a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the appointment of Jodi Ungrodt to its Board of Directors, where she will also serve as Chair of the Audit Committee, effective March 18, 2026.\"I am excited to welcome Jodi to our board as we undertake this expansion of our business beyond chronic wound care,\" said Jason Matuszewski, Chairman and CEO of BioStem Technologies. \"Along with the business expansion, we also plan to raise our profile in the public markets in 2026. Jodi's twenty-nine years of life sciences accounting experience at Ernst & Young, along with her track record advising more than thirty IPOs and deep regulatory and government expertise, will make a terrific addition to our board governance during this pivotal time.\". Ungrodt holds a BS in Accounting from San Diego State University and is a Cert","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4588","BK4099","BSEM","BK4555","BK4007","BK4585","03160","BK4232","BK4022","R","BK4604"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":26,"code":"91000000","status":"200"}]}}